LaVoieHealthScience (LHS), an integrated strategic communications agency that is focused on health and life science, today announced the appointment of Martin Forrest as Senior Vice President. Focusing on strategy, branding, and reputation, Forrest brings strategic counsel to new and existing clients. This new position is a response to significant growth of existing and new clients.

Forrest has expertise in enterprise communication, policy and advocacy along with deep knowledge and passion for global health with proven experience across device, biotech, and pharmaceutical settings. Prior to joining LHS, he served as the founding vice president of communications for Zoetis, the largest global animal health company, which was spun out of Pfizer, Inc. Zoetis boasted the second largest Initial Public Offering of 2013. Previously, he led market access and patient advocacy for Novartis Oncology in Latin America, and prior to that was vice president of investor relations and communications for Chiron Corporation. Earlier in his career, he held commercial roles promoting device therapies for end-stage kidney and heart disease at Baxter Healthcare.

“Martin brings to LHS the experience of working on the client side through his senior roles at leading device, biotech, and pharmaceutical companies,” said Donna L. LaVoie, President and CEO. “His background provides our clients a pragmatic and integrated perspective across the stakeholder mix. Martin is an important strategic addition, and we are delighted to welcome him to the LHS team.”

Forrest said, “I am excited to be joining LHS in the dynamic Cambridge life science hub after cutting my teeth in the San Francisco Bay Area biotech community earlier in my career. LHS has grown by serving a dynamic group of biopharma, medical device and other clients with an integrated approach to communication. I am pleased to join a team of seasoned health and life science practitioners and look forward to working with the agency’s leading health science clients.”

About LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 27 awards over the past six years in recognition of the work it has done for its industry-leading clients. The agency maintains a comprehensive list of investor, partnering and medical conferences which can be found here.

LaVoieHealthScience is ranked by O’Dwyer’s PR as one of the Top 40 Independent Healthcare PR firms in the U.S.

Editor’s Note: Photo Available Upon Request